Gymnastik- och idrottshögskolan, GIH

System disruptions
There are recurring service disruptions on some of the search portals due to high traffic. We are working to resolve the issue, you may temporarily encounter an error message.
Change search
Link to record
Permanent link

Direct link
Alternative names
Publications (1 of 1) Show all publications
Zhang, L., Laaniste, L., Jiang, Y., Alafuzoff, I., Uhrbom, L. & Dimberg, A. (2016). Pleiotrophin enhances PDGFB-induced gliomagenesis through increased proliferation of neural progenitor cells. Oncotarget, 7(49), 80382-80390
Open this publication in new window or tab >>Pleiotrophin enhances PDGFB-induced gliomagenesis through increased proliferation of neural progenitor cells
Show others...
2016 (English)In: Oncotarget, E-ISSN 1949-2553, Vol. 7, no 49, p. 80382-80390Article in journal (Refereed) Published
Abstract [en]

Pleiotrophin (PTN) augments tumor growth by increasing proliferation of tumor cells and promoting vascular abnormalization, but its role in early gliomagenesis has not been evaluated. Through analysis of publically available datasets, we demonstrate that increased PTN mRNA expression is associated with amplification of chromosome 7, identified as one of the earliest steps in glioblastoma development. To elucidate the role of PTN in tumor initiation we employed the RCAS/tv-a model that allows glioma induction by RCAS-virus mediated expression of oncogenes in neural progenitor cells. Intracranial injection of RCAS-PTN did not induce glioma formation when administrated alone, but significantly enhanced RCAS-platelet derived growth factor (PDGF) B-induced gliomagenesis. PTN co-treatment augmented PDGFBinduced Akt activation in neural progenitor cells in vitro, and enhanced neural sphere size associated with increased proliferation. Our data indicates that PTN expression is associated with chromosome 7 gain, and that PTN enhances PDGFB-induced gliomagenesis by stimulating proliferation of neural progenitor cells.

Keywords
glioma, pleiotrophin, gliomagenesis, tumor initiation, chromosome 7
National Category
Cancer and Oncology
Identifiers
urn:nbn:se:gih:diva-7946 (URN)10.18632/oncotarget.12983 (DOI)000389877500027 ()
Funder
Swedish Cancer Society, CAN 2011/862 CAN 2014/832 CAN 2015/1216Swedish Childhood Cancer Foundation, PR2013-0107 PR2015-0133 NCp2015-0075Swedish Research Council, 2013-3797
Available from: 2023-11-16 Created: 2023-11-16 Last updated: 2025-09-16
Projects
Endothelial activation during cancer progression - molecular mechanisms and clinical relevance [2008-02709_VR]; Uppsala UniversityEndothelial activation during cancer progression - molecular mechanisms and clinical relevance [2008-02853_VR]; Uppsala UniversityMolecular regulation of vascular abnormalization and its role in tumor progression in glioblastoma [2013-03797_VR]; Uppsala UniversityThe vasculature as a target for therapy in brain tumors [2016-02495_VR]; Uppsala UniversityThe vasculature as a target for therapy in brain tumors [2020-02563_VR]; Uppsala UniversityBoosting CAR-T cells for improved cancer immunotherapy [2023-02232_VR]; Uppsala UniversityNext generation vascular targeting for brain tumors [2024-03125_VR]; Uppsala University
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0003-4422-9125

Search in DiVA

Show all publications